Att 05 Deliverables.pdf
PDF 55 KB Posted
- Attached to
- Novel Technologies in Newborn Screening Federal contract opportunity
- Solicitation number
- NIH-NICHD-CDBPM-10-15-PS
About this file
Attachment No. 5 - Deliverables and/or Reporting Requirements
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Referenced FDA Document from Att 04.pdf | ||
| Att 01 Packaging and Delivery of Proposals.pdf | ||
| Att 04 Additional Technical Instructions.pdf | ||
| Att 02 Proposal Intent Response Sheet.pdf | ||
| Att 03 SOW.pdf | ||
| NIH-NICHD-CDBPM-10-15-RFP.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
NIH-NICHD-CDBPM-10-15-RFP - Attachment 5 Page 1 of 2
DELIVERABLES AND/OR REPORTING REQUIREMENTS
RFP No.: NIH-NICHD-CDBPM-10-15-RFP
RFP Title: Novel Technologies in Newborn Screening
The Contractor shall provide the reports and deliverables specified below. All reports shall be submitted in electronic form as PC-formatted computer files in Microsoft Word and Microsoft Excel and/or searchable PDF format. All reports shall be archived on CD or other appropriate media for provision to the Project Officer at the expiration of the contract.
A. Final Protocols
In accordance with the Statement of Work, item #3, the final protocols for the development of the technology platform component and the bioinformatics component shall be submitted 15 days prior to the expiration date of the contract.
B. Monthly Status Report
A monthly status report, providing a brief (no longer than one page, double spaced) description of the project that covers the preceding 30 days, shall be submitted on the first day of each month for the first year of the three-year project.
C. A quarterly progress report detailing:
1. Face page to include:
a) contract number
b) title
c) period of performance being reported
d) Offeror's name and address, telephone and fax numbers
e) date of submission.
2. An executive summary to include:
a) A statement of intended work for the reporting period
b) A brief overview of the work completed for the reporting period and/or justification for intended work not completed or unintended work performed
c) A brief overview of the activities that occurred during the current reporting period and any problems (technical or financial) that occurred during the current reporting period
d) The advancements made in relation to any of the specific aims or milestones set forth in the Statement of Work;
3. A full description of:
a) The work performed during the reporting period
b) The relationship with state newborn screening laboratory
c) The relationship between the accomplishments to the goals, objectives, and milestones of the Statement of Work; and
d) A full discussion of the results and their relevance; explanations of any differences between planned and actual progress; and, if necessary, what corrective steps the
Contractor plans.
NIH-NICHD-CDBPM-10-15-RFP - Attachment 5 Page 2 of 2
4. A summary of activities planned for the next reporting period.
5. Copies of manuscripts (published or unpublished) derived from research under the contract and copies of all abstracts, manuscripts, preprints and publications that resulted from work conducted or any protocol or method developed specifically under this contract during the performance period.
6. The first reporting period consists of the first full three months of performance including any fractional part of the initial month. Thereafter, the reporting period shall consist of three full calendar months. NlCHD does not require a Quarterly Progress report at the time when the final report is due. The Offeror shall submit quarterly reports within thirty days of the end of each 3-month period.
D. Technology Prototype and Final Report:
a) The full-sized functional model (prototype) or experimental design will be delivered to
NICHD's office in Bethesda, Maryland. All protocols used in conjunction with the technology as well as all bioinformatics components must be delivered with the prototype, which includes its software and all source codes.
b) The report shall also include:
i) Results of Comparative Effectiveness Analysis (if applicable)
ii) Technical Research Plan
iii) Measurement Plan
iv) Performance Plan
v) Quality Assurance Plan
vi) Specifics of bioinformatics platform for data collection and analysis
c) The final report is to include a summation of the work performed and results obtained for the entire contract period of performance. This report shall contain sufficient detail to describe comprehensively the results achieved and provide the final outcomes based on the contract's performance metrics and quality assurance plan. Information requested in the Statement of
Work section (i.e. utility of the technology, performance characteristics) shouId also be included in the final report. The Offeror shall submit the final report and make a presentation of the final report to NlCHD in Bethesda, Maryland 15 days prior to the expiration date of the contract.
E. Summary of Salient Results:
a) The Contractor shall submit, with the Final Report, a summary (not to exceed 200 words) of salient results achieved during the performance of the contract. The Contractor shall submit this document 15 days prior to the expiration date of the contract.
File details come from the government source that posted it. Updated .